Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News XWELL Inc XWEL

XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:XWEL)

No current opinion is available.

Bullboard Posts (NDAQ:XWEL)

XWELL, Inc. (NASDAQ:XWEL): Navigating Turbulence, Charting a

http://beyondspx.com/2024/08/02/xwell-inc-nasdaqxwel-navigating-turbulence-charting-a-path-to-profitability/
MikeTester - August 3, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Alfonsou - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Alfonsou - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
Alfonsou - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Alfonsou - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Alfonsou - May 11, 2022